Hepatogenous Diabetes: A Comprehensive Overview
), Sharon Sandra(2),
(1) Department of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan, Tangerang
(2) Faculty of Medicine, Universitas Nusa Cendana, Kupang, Indonesia
Corresponding Author
Abstract
Cirrhosis is the advanced stage of liver disease, marked by the presence of liver fibrosis. Cirrhosis serves as a risk factor for various metabolic conditions, including hypoglycemia and hyperglycemia. Although the pathophysiology remains unclear, hyperglycemia can occur due to the interaction of various factors, such as insulin resistance. The prevalence of both diabetes mellitus and cirrhosis is increasing, and their interaction influences each other’s outcomes. Hepatogenous diabetes (HD) refers to diabetes mellitus that develops in patients with cirrhosis. HD is diagnosed using an oral glucose tolerance test, which typically reveals elevated postprandial blood glucose levels. The management of HD follows the same principles as diabetes mellitus treatment; however, pharmacological therapy should be individualized based on the patient’s liver function to ensure optimal outcome. The objective of this review is to provide a comprehensive discussion of HD, encompassing its pathophysiology, clinical implications, diagnostic approaches, and management strategies.
Keywords
References
Elkrief L, Rautou P, Sarin S, Valla D, Paradis V, Moreau R. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int. 2016;36(7):936-48.
Yen F, Hou M, Liu J, Hsu C, Hwu C. Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes. Front Med (Lausanne). 2022;9(962337).
Tolman K, Fonseca V, Dalpiaz A, Tan M. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30(3):734-43.
Kumar R. Hepatogenous diabetes: An underestimated problem of liver cirrhosis. Indian J Endocrinol Met. 2018;22:552-9.
Smith A, Baumgartner K, Bositis C. Cirrhosis: diagnosis and management. Am Fam Physician. 2019;100(12):759-70.
Kalista K, Lesmana C, Sulaiman A, Gani R, Hasan I. Clinical profile of cirrhotic patient with esophageal varices who undergo band ligation in Cipto Mangunkusumo Hospital. J Penyakit Dalam Indones. 2019;6:36-41.
Prasetya I, Hasan I, Wisnu W, Rumende C. Prevalence and profile of fibrosis in diabetic patients with non-alcoholic fatty liver disease and the associated factors. Acta Med Indones. 2017;49(2):91-98.
Orsi E, Grancini V, Menini S, Aghemo A, Pugliese G. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? Liver Int. 2017;37(7):950-62.
Khan M, Hashim M, King J, Govender R, Mustafa H, Al Kaabi J. Epidemiology of type 2 ddiabetes - Global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10:107-11.
Lee W, Wells C, McCall J, Murphy R, Plank L. Prevalence of diabetes in liver cirrhosis: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35(6):e3157.
Kumar R, Garcia-Compean D, Maji T. Hepatogenous diabetes: Knowledge, evidence, and skepticism. World J Hepatol. 2022;14(7):1291-306.
Itou M, Kawaguchi T, Taniguchi E, Sata M. Dipeptidyl peptidase-4: a key player in chronic liver disease. World J Gastroenterol. 2013;19(15):2298-306.
Vrieze A, Van Nood E, Holleman F, Salojarvi J, Koote RS, Bartelsman J, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterol. 2012;143(4):913-16.
Eslamparast T, Montano-Loza A, Raman M, Tandon P. Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans. 2018;38(10):1706-17.
Boursier J, Anty R, Carette C, Cariou B, Castera L, Caussy C, et al. Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. Diabetes Metab. 2021;47(5):101272.
Chen H, Shieh J, Chang C, Chen TT, Lin J, Wu M, et al. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut. 2013;62(4):606-15.
Article Metrics
Abstract View
: 150 times
Download : 118 times
DOI: 10.24871/2632025268-273
Refbacks
- There are currently no refbacks.
